Navigation Links
Promising new compound for treating stroke
Date:2/21/2012

Researchers at the University of Copenhagen have designed, produced and patented a new chemical compound for the possible treatment of brain damage caused by stroke. The compound binds 1,000 times more effectively to the target protein in the brain than the potential drug currently being tested on stroke victims. The results of biological tests have just been published in the renowned journal PNAS.

More than 140,000 people die each year from stroke in the United States. Stroke causes the brain to release large amounts of glutamate, an activating signal compound, all at once. This overactivates the receptors in the surrounding healthy tissue, causing the level of calcium in the cells to rise dramatically. This then kick-starts a toxic chain reaction causing cell death. Scientists believe that this process is the cause of the brain damage that occurs in the wake of a stroke. Therefore they are looking for compounds that can limit cell death:

"Research on animal models shows that the new compound we have designed and produced reduces the dead area in the brain after a stroke by 40 per cent. In addition, we can show that our compound is far more biologically effective than the potential drug currently being tested in clinical trials," explains Anders Bach, medicinal chemist and postdoc at the Faculty of Health and Medical Sciences.

Improving motor function in animals

A research project based at the Faculty of Health and Medical Sciences is the catalyst for the development of drugs to treat brain damage resulting from stroke. A new chemical compound has shown to be extremely potent, binding 1,000 times better than the potential drug currently under clinical development. Biological tests also indicate that the new compound shows high biological activity in animal models and is able to pass through the nearly impermeable blood-brain barrier, which is otherwise a fundamental challenge in clinical drug development. The result
'/>"/>

Contact: Anders Bach
anba@farma.ku.dk
(45) 40-32-08-06
University of Copenhagen
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Promising early results with therapeutic cancer vaccines
2. Massage is promising for muscle recovery
3. State of the Union speech: Promising outlook for research and innovation
4. Deep brain stimulation shows promising results for unipolar and bipolar depression
5. WISeKey General Assembly Votes Unanimously to Propel the Company into a Promising and Disruptive Future
6. Improved rainwater harvesting system promising
7. Fate Therapeutics Announces Promising Data From Phase 1b Study of ProHema at the 2011 American Society of Hematology Annual Conference
8. Promising results in mice on needle-free candidate universal vaccine against various flu viruses
9. More promising natural gas storage?
10. Progeria: Promising results from new gene therapy on animals
11. New method of growing high-quality graphene promising for next-gen technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 2015 Synaptics, Inc. (Nasdaq: SYNA ), ... that members of the executive management team will present ... Technology Leadership Forum on Tuesday, August 11, 2015 at ... at the Sonnenalp Resort in Vail, CO. ... forward-looking information. An audio webcast of the event will ...
(Date:7/31/2015)... SHENZHEN, China , 31 de julho de 2015 ... Genômica (ICG-10, www.icg-10.org ) será realizada pela BGI de ... China . A conferência está ... inauguração em 2006, a ICG se tornou uma das ... e um dos encontros científicos mais dinâmicos, entusiastas e ...
(Date:7/31/2015)... Die 10. internationale Konferenz zu Genomik (ICG-10, ... vom 22. bis 25. Oktober 2015 in ... Die Konferenz feiert in diesem Jahr ihr ... ICG weltweit zu einem der einflussreichsten jährlichen Treffen ... dynamischsten, enthusiastischsten und angenehmsten wissenschaftlichen Zusammentreffen. ...
Breaking Biology News(10 mins):A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3
... will publish research that demonstrates how a biosensor can detect ... step in identifying and fighting superbugs, a major public health ... the United States in recent years. The technology is ... University and the Keesler Air Force Base with funding from ...
... Scientists have discovered that fat cells in the knee ... the way for new gene therapies that could offer relief ... in the knee joints secretes a protein called pro-factor D ... that is linked to arthritis," said Nirmal Banda, Ph.D., associate ...
... May 7, 2013 From New York City,s Central Park ... store an estimated 708 million tons of carbon, an environmental ... a recent U.S. Forest Service study. Annual net ... tons and $1.5 billion in economic benefit. In the ...
Cached Biology News:Biosensor that detects antibiotic resistance brings us one step closer to fighting superbugs 2Discovery shows fat triggers rheumatoid arthritis 2US urban trees store carbon, provide billions in economic value 2US urban trees store carbon, provide billions in economic value 3US urban trees store carbon, provide billions in economic value 4US urban trees store carbon, provide billions in economic value 5US urban trees store carbon, provide billions in economic value 6
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... Since the initial launch of FireflySci Inc. ... quirky humor and excellent customer service. Images such as the Fonz in a lab ... add some flavor to the humdrum spectroscopy field. , FireflySci is proud to ...
(Date:8/27/2015)... , Aug. 27, 2015 The National ... patient,s eyes—and life—were saved by doctors at Vanderbilt University ... with NNFF, NovaBay Pharmaceuticals and Dr. John Crew ... at Seton Medical Center in Daly ... used a breakthrough approach, pioneered by Dr. Crew, that ...
(Date:8/27/2015)... ... ... Inc. Magazine released its annual list of the 5,000 fastest-growing privately held ... the three years through 2014. Being named to the Inc. 5000 list designates a ... , “We are thrilled to make the Inc. 5000 list for 2015,” stated ...
(Date:8/26/2015)... 2015 /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended June 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... to our Oral Amp B program, rapidly advancing ... Andrew Rae , President & CEO of ...
Breaking Biology Technology:Cuvette Manufacturer FireflySci Launches Back to School Deals with Complimentary Shipping On All Orders 2Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 2Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 3iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3
... CALGARY, May 1 /PRNewswire-FirstCall/ - Resverlogix Corp.,("Resverlogix") (TSX:RVX) ... a live,teleconference on May 8, 2008 at 9:00 ... the science and the business aspects of the ... question and answer session., The webcast can ...
... May 1 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ... and,medical device company, today announced that it has ... Administration (FDA) to begin,marketing sizes 3-0 and 4-0 ... line. The Quill SRS PDO is a longer-lasting,absorbable ...
... (Nasdaq: RNVS ) announced today that its stockholders ... (Frankfurt Stock Exchange:,EVT) at a special meeting of stockholders ... 5, 2008., In the transaction, each issued and ... into the right to receive 0.5271 of,an American Depositary ...
Cached Biology Technology:Resverlogix Notice of Conference Call & Webcast 2Angiotech Expands Quill(TM) SRS product offering receiving FDA 510(k) approval for smaller size diameters of Quill(TM) SRS PDO 2Angiotech Expands Quill(TM) SRS product offering receiving FDA 510(k) approval for smaller size diameters of Quill(TM) SRS PDO 3Angiotech Expands Quill(TM) SRS product offering receiving FDA 510(k) approval for smaller size diameters of Quill(TM) SRS PDO 4Renovis Stockholders Approve Acquisition by Evotec 2
... B-Bridge's siSolutions RNAi Services offer ... for your siRNA studies. B-Bridges advanced ... and technical expertise ensure that you ... experiments. siSolutions siRNA Design Service utilizes ...
... Complete Solution Polymorphic DNA ... We provide a complete solution for SNP ... assay design, oligonucleotide primers, PCR amplification, DNA ... For SNP discovery, Polymorphic uses ...
... The mini ReadySub-Cell GT cell and PowerPac basic ... electrophoresis of nucleic acids in agarose gels. The ... with cables and electrodes, and leveling bubble. The ... provides output of 10-300 V, 4-400 mA, and ...
... This CE-based system provides clear ... quantitation (viral load, gene expression), mutation ... The easy-to-use system with microplate connectivity ... development, and quality control. The ...
Biology Products: